{{Multiple issues|
{{Original research|time=2020-10-04T15:04:20+00:00}}
{{Refimprove|time=2020-10-04T15:04:20+00:00}}
}}
{{medical}}
{{drugbox
| Watchedfields = changed
| verifiedrevid = 443526033
| drug_name = 
| IUPAC_name = 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
| image = Ciprofloxacin.svg
| width = 200
| image2 = Ciprofloxacin-zwitterion-from-xtal-3D-balls.png

<!--Clinical data-->
| tradename = Ciloxan, Cipro, Neofloxin, others
| Drugs.com = {{drugs.com|monograph|ciprofloxacin-hydrochloride}}
| MedlinePlus = a688016
| licence_US = Ciprofloxacin
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[给药途径|口服]]、[[靜脈注射|靜脈注射]]、[[外用藥物|外用藥物]]（{{tsl|en|ear drop|耳滴劑}}、[[眼藥水|眼藥水]]）

<!--Pharmacokinetic data-->
| bioavailability = 70%<ref name="pmid17154673">{{cite journal |pmid=17154673 |year=2006 |author1=Zhanel |first1=G. G. |title=A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections |journal=Treatments in respiratory medicine |volume=5 |issue=6 |pages=437–65 |last2=Fontaine |first2=S |last3=Adam |first3=H |last4=Schurek |first4=K |last5=Mayer |first5=M |last6=Noreddin |first6=A. M. |last7=Gin |first7=A. S. |last8=Rubinstein |first8=E |last9=Hoban |first9=D. J. }}</ref>
| protein_bound = 30%<ref name="pmid17154673" />
| metabolism = [[肝臟|肝臟]]（[[CYP1A2|CYP1A2]]及其他）
| elimination_half-life = 3.5 小時<ref name="pmid17154673" />
| excretion = [[腎|腎]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 85721-33-1
| ATC_prefix = J01
| ATC_suffix = MA02
| ATC_supplemental =  {{ATC|S01|AE03}} {{ATC|S02|AA15}} {{ATC|S03|AA07}}
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 100241
| PubChem = 2764
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00537
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2662
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5E8K9I0O4U
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00186
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 8
| NIAID_ChemDB = 001992

<!--Chemical data-->
| C=17 | H=18 | F=1 | N=3 | O=3
| molecular_weight = 331.346 g/mol
| smiles = c1c2c(cc(c1F)N3CCNCC3)n(cc(c2=O)C(=O)O)C4CC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MYSWGUAQZAJSOK-UHFFFAOYSA-N
}}
<!-- Definition and medical uses -->
'''环丙沙星'''（{{lang|en|Ciprofloxacin}}）是第二代[[喹诺酮|氟喹诺酮]]类化合{{tsl|en|Broad-spectrum antibiotic|廣效抗細菌藥|廣效抗生素}}<ref name=AHFS2015/>，可對抗多種[[病原细菌|病原菌]]<ref name=AHFS2015>{{cite web|title=Ciprofloxacin Hydrochloride|url=http://www.drugs.com/monograph/ciprofloxacin-hydrochloride.html|publisher=The American Society of Health-System Pharmacists|accessdate=Aug 23, 2015|archive-date=2017-08-13|archive-url=https://web.archive.org/web/20170813014450/https://www.drugs.com/monograph/ciprofloxacin-hydrochloride.html|dead-url=no}}</ref>。治療範圍包含骨骼感染、[[敗血性關節炎|關節感染]]、腹部感染，以及特定幾種[[腸胃炎|感染性腸胃炎]]、[[呼吸道感染|呼吸道感染]]、皮膚感染、[[伤寒|伤寒]]，以及[[泌尿道感染|泌尿道感染]]等等<ref name=AHFS2015/>。本品亦可配合其他抗生素進行治療<ref name=AHFS2015/>，可經口服或靜脈注射給藥<ref name=AHFS2015/>。

<!-- Side effects and mechanism-->
常見副作用包含噁心、嘔吐、腹瀉，以及皮膚紅疹<ref name=AHFS2015/>，還會增加{{tsl|en|tendon rupture|肌腱斷裂}}風險，且[[重症肌無力|重症肌無力]]患者服用後肌肉無力的症狀可能惡化<ref name=AHFS2015/>。副作用發生的機率較[[頭孢菌素|頭孢菌素]]高，但較[[克林黴素|克林黴素]]低<ref name=He2013>{{cite journal |pmid=23570031 |url=http://www.jfponline.com/Pages.asp?AID=11235 |year=2013 |author1=Heidelbaugh |first1=J. J. |title=The perils of prescribing fluoroquinolones |journal=The Journal of family practice |volume=62 |issue=4 |pages=191–7 |last2=Holmstrom |first2=H |access-date=2017-07-01 |archive-date=2021-08-28 |archive-url=https://web.archive.org/web/20210828035924/https://www.mdedge.com/familymedicine/article/65086/perils-prescribing-fluoroquinolones |dead-url=yes }}</ref>。動物實驗表明[[妊娠|妊娠]]期間用藥可能具有些微風險<ref name=AG2015/>，孕婦服用有少數胎兒產生問題<ref name=AG2015>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|date=23 Aug 2015|accessdate=2017-07-01|archive-date=2014-04-08|archive-url=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|dead-url=no}}</ref>。[[母乳哺育|哺乳]]期間用藥目前顯示安全<ref name=AHFS2015/>。本品透過抑制細菌的[[DNA旋轉酶|DNA旋轉酶]]達到殺菌的效果<ref name=AHFS2015/><ref>{{cite journal |doi=10.1093/oxfordjournals.jac.a020889 |pmid=10997595 |title=Quinolone generations: Natural history or natural selection? |journal=Journal of Antimicrobial Chemotherapy |volume=46 |pages=17–24 |year=2000 |last1=Ball |first1=P. }}</ref><ref>{{cite journal |pmid=11858629 |url=http://www.aafp.org/link_out?pmid=11858629 |year=2002 |author1=Oliphant |first1=C. M. |title=Quinolones: A comprehensive review |journal=American family physician |volume=65 |issue=3 |pages=455–64 |last2=Green |first2=G. M. |access-date=2017-07-01 |archive-date=2021-08-28 |archive-url=https://web.archive.org/web/20210828035924/https://www.aafp.org/afp/2002/0201/p455.html |dead-url=no }}</ref>。

<!-- History, society and culture -->
环丙沙星於1987年首次發現<ref>{{cite book|title=Oxford Handbook of Infectious Diseases and Microbiology|date=2009|publisher=OUP Oxford|isbn=978-0-19-103962-1|page=56|url=https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56|access-date=2017-07-01|archive-date=2015-11-24|archive-url=https://web.archive.org/web/20151124232554/https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56|dead-url=no}}</ref>，並列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|archive-date=2016-12-13|archive-url=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|dead-url=no}}</ref>。本品屬於[[通用名药物|通用名药物]]，價格不貴<ref name=AHFS2015/><ref name=Ric2014>{{cite book|last1=Hamilton|first1=Richard J.|title=Tarascon pharmacopoeia|date=2014|publisher=Jones & Bartlett Publishers|isbn=978-1-284-05671-6|page=85|edition=15|url=https://books.google.ca/books?id=F6YdAwAAQBAJ&pg=PA85|access-date=2017-07-01|archive-date=2016-03-05|archive-url=https://web.archive.org/web/20160305033318/https://books.google.ca/books?id=F6YdAwAAQBAJ&pg=PA85|dead-url=no}}</ref>。[[发展中国家|发展中国家]]每劑批發價約介於0.03至0.13美金之間<ref name=ERC2015>{{cite web|title=Ciprofloxacin|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=CIP500T&s_year=2014&year=2014&str=500%20mg&desc=Ciprofloxacin&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E2%2E2%2E&supplement=&class_name=%2806%2E2%2E2%2E%29Other%20antibacterials%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=24 August 2015}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>，美國每劑則約0.40美金<ref name=AHFS2015/>。

== 适应症 ==
在美国此药被批准用于给成人治疗以下已检验出的病菌感染：
* [[泌尿道感染|泌尿道感染]]感染（推荐作为首选抗生素）<ref>{{cite web |title=Fluroquinolone Drug Class Review |url=http://pharmacy.oregonstate.edu/drug_policy/pages/dur_board/reviews/articles/fluroquinolone-lit.html |publisher=Oregon State University College of Pharmacy |year=2002 |accessdate=4 September 2009 |deadurl=yes |archiveurl=https://web.archive.org/web/20090221121051/http://pharmacy.oregonstate.edu/drug_policy/pages/dur_board/reviews/articles/fluroquinolone-lit.html |archivedate=2009年2月21日 }}</ref>
* 女性急性[[膀胱炎|膀胱炎]]并发症
* 慢性细菌性[[前列腺|前列腺]]炎（推荐作为首选抗生素）
* [[下呼吸道感染|下呼吸道感染]]（不推荐作为首选抗生素）<ref>{{cite journal |pmid=15492337 |url=http://www.annals.org/cgi/content/full/141/8/581 |journal=Annals of Internal Medicine |title=Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial |volume=141 |issue=8 |page=581 |date=October 19, 2004 |issn=0003-4819 |author1=Alexander, Richard B |author2=Propert, Kathleen J |author3=Schaeffer, Anthony J |author4=Landis, J. Richard |author5=Nickel, J. Curtis |author6=O'Leary, Michael P |author7=Pontari, Michel A |author8=McNaughton-collins, Mary |author9=Shoskes, Daniel A |author10=Comiter, Craig V |author11=Datta, Nand S |author12=Fowler, Jackson E |author13=Nadler, Robert B |author14=Zeitlin, Scott I |author15=Knauss, Jill S |author16=Wang, Yanlin |author17=Kusek, John W |author18=Nyberg, Leroy M |author19=Litwin, Mark S |author20=Network*, and the Chronic Prostatitis Collaborative Research |quote=did not substantially reduce symptoms in men with long-standing CP/CPPS who had at least moderate symptoms. |access-date=2010-03-22 |archive-date=2009-08-15 |archive-url=https://web.archive.org/web/20090815111752/http://www.annals.org/cgi/content/full/141/8/581 |dead-url=no }}</ref><ref>{{cite web |author=J. Dimitrakov |coauthors=J. Tchitalov, T. Zlatanov, D. Dikov |title=A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Of Antibiotics For The Treatment Of Category Iiib Chronic Pelvic Pain Syndrome In Men |url=http://www.prostatitis.org/a92000.html |publisher=Third International Chronic Prostatitis Network |accessdate=4 September 2009 |archive-date=2010-06-19 |archive-url=https://web.archive.org/web/20100619202954/http://prostatitis.org/a92000.html |dead-url=no }}</ref>
* 急性[[鼻窦炎|鼻窦炎]]（不推荐作为首选抗生素）<ref name="Karageorgopoulos-2008">{{Cite journal | last1 = Karageorgopoulos | first1 = DE. | last2 = Giannopoulou | first2 = KP. | last3 = Grammatikos | first3 = AP. | last4 = Dimopoulos | first4 = G. | last5 = Falagas | first5 = ME. | title = Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. | journal = CMAJ | volume = 178 | issue = 7 | pages = 845–54 | doi = 10.1503/cmaj.071157 | pmid = 18362380 | url = http://www.cmaj.ca/cgi/content/full/178/7/845 | pmc = 2267830 | date = March 2008 | access-date = 2010-03-22 | archive-date = 2010-02-06 | archive-url = https://web.archive.org/web/20100206202622/http://www.cmaj.ca/cgi/content/full/178/7/845 | dead-url = no }}</ref>
* [[皮肤|皮肤]]和皮肤结构感染
* [[骨部|骨]]和[[关节|关节]]感染
* 感染性[[腹泻|腹泻]]
* [[伤寒|伤寒]]（肠溶热）（伤寒杆菌导致）
* 单纯性颈部及尿道[[淋病|淋病]]（淋球菌导致） - 但一些地区因为抗药性而不再有效（[[亚洲|亚洲]]国家，[[美国|美国]]（包括[[夏威夷|夏威夷]]），[[加拿大|加拿大]]，和[[苏格兰|苏格兰]]）。在美国不再推荐用于这类治疗。<ref>(World Health Organization (WHO) Western Pacific Region Gonococcal Antimicrobial Susceptibility Programme (GASP) Report- 2000. Commun Dis Intell 2001; 25:274-277).
</ref><ref>{{cite web |author=DEPARTMENT OF HEALTH AND HUMAN SERVICES |authorlink=DEPARTMENT OF HEALTH AND HUMAN SERVICES |coauthors=[[美国疾病控制与预防中心|Centers for Disease Control and Prevention]] |title=Gonococcal Isolate Surveillance Project (GISP) Annual Report - 2003 |url=http://www.cdc.gov/STD/gisp2003/GISP2003.pdf |publisher=Center for Disease Controlo |location=USA |format=PDF |accessdate=31 August 2009 |date=November 2004 |archive-date=2009-04-24 |archive-url=https://web.archive.org/web/20090424062831/http://www.cdc.gov/std/GISP2003/GISP2003.pdf |dead-url=no }}</ref><ref>{{cite journal |author=Hugh Young |date=22 July 2003 |title=Ciprofloxacin resistant gonorrhoea: the situation in Scotland and implications for therapy |journal=SCIEH Weekly Report - SCOTTISH CENTRE FOR INFECTION AND ENVIRONMENTAL HEALTH |volume=37 |publisher=National Health Service |location=Scotland |issn=1357-4493 |doi= |url=http://www.documents.hps.scot.nhs.uk/ewr/pdf2003/0329.pdf |format=PDF |access-date=2010-03-22 |archive-url=https://web.archive.org/web/20110722204213/http://www.documents.hps.scot.nhs.uk/ewr/pdf2003/0329.pdf |archive-date=2011-07-22 |dead-url=yes }}</ref><ref>{{cite journal |date=13 April 2007 |title=Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. |journal=Morbidity and Mortality Weekly Report |volume=56 |issue=14 |pages=332–336 |publisher=Center for Disease Control |location=USA |url=http://www.ct.gov/dph/lib/dph/infectious_diseases/std/stdupdatemmwr.pdf |format=PDF |accessdate=31 August 2009 |pmid=17431378 |author1=Centers for Disease Control and Prevention (CDC) |archive-date=2014-04-13 |archive-url=https://web.archive.org/web/20140413143710/http://www.ct.gov/dph/lib/dph/infectious_diseases/std/stdupdatemmwr.pdf |dead-url=no }}</ref>

环丙沙星不建议用于治疗[[结核病|结核病]]。<ref>{{cite journal |pmid=16034951 |title=Fluoroquinolones for treating tuberculosis. |volume= |issue=3 |pages=CD004795 |issn= |doi=10.1002/14651858.CD004795.pub2 |journal=Cochrane database of systematic reviews (Online) |first1=LE |first2=AA |first3=SB |last1=Ziganshina |last2=Vizel |last3=Squire |first4=Lilia |last4=Ziganshina |date=July 2005}}</ref>

以及结合其他具体药物：
* 复杂腹腔感染（与[[甲硝唑|甲硝唑]]联合使用） 
* 实践中可治疗发热性中性粒细胞减少（与[[哌拉西林|哌拉西林]]联合使用）

==副作用==
注意：氟喹诺酮类抗生素有可能导致肌腱炎，韧带断裂，软骨和软组织疼痛。这种状况经常是在停药很久之后发生，比如几周或几个月之后发生，届时病人和医生都很难把这种副作用和该药物关联起来，这造成了大量的副作用的发生没有被计入医学统计，从而降低了医生和病人对该类药物副作用的重视程度。这被为数不少的副作用受害者认为是一个普遍存在，却没有引起重视的医疗问题乃至社会问题。受害者甚至都不知道自己的长期“神秘”疼痛是来自于氟喹诺酮类抗生素。

2013年8月15日， 美国食品药品监督管理局（FDA）要求更新所有氟喹诺酮类抗生素的药品说明书和用药指南，以更好的描述周围神经病变这一严重副作用。由氟喹诺酮类药品引起的严重神经损害可能在使用这些药物不久后发生，且可能不可逆转。周围神经病变仅发生于喹诺酮类药物的口服或注射制剂。外用氟喹诺酮类制剂（滴耳剂或滴眼剂）与该风险不相关。如果患者出现周围神经病变症状，应停用氟喹诺酮类药物，换用其他非喹诺酮类抗生素，除非继续使用氟喹诺酮类治疗的获益大于风险。周围神经病变是一种发生于手臂或腿部的神经病变。症状包括疼痛、灼热感、刺痛、麻木、无力，或轻触感、痛感或温度感发生改变。周围神经病变可发生于氟喹诺酮类治疗期间的任何时间，且在药物停用后可持续数月至数年，或为永久性改变。

==药物互相作用==
{{le|藥物安全委員會|Committee on Safety of Medicines}}和[[美國食品藥品監督管理局|美國食品藥品監督管理局]]警告：當[[非類固醇消炎藥|非類固醇消炎藥]]與[[喹諾酮|喹諾酮]]類藥物合併使用，[[中樞神經系統|中樞神經系統]]的[[不良反應_(醫學)|不良反應]]包括[[癲癇|癲癇]]發作風險可能會增加<ref name=ctcos>{{cite web |title=Cipro Labeling Revision 10/03/2008 Supplement 068 |url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019537s68,19847s42,19857s49,20780s26,21473s24lbl.pdf |publisher=U.S. [[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) |date=3 October 2008 |access-date=31 August 2009 |deadurl=yes |archive-url=https://web.archive.org/web/20101214110353/http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019537s68,19847s42,19857s49,20780s26,21473s24lbl.pdf |archive-date=2010-12-14 }}</ref><ref>{{cite book |title=British National Formulary (BNF 57) |author=Royal Pharmaceutical Society of Great Britain |publisher=BMJ Group and RPS Publishing |chapter=5 Infections |year=2009 |isbn=978-0-85369-845-6  }}</ref>。這種相互作用的機制可能涉及[[協同效應|協同]]增強[[GABA|GABA]]神經傳遞的拮抗作用<ref name="pmid11172695">{{cite journal | vauthors = De Sarro A, De Sarro G | title = Adverse reactions to fluoroquinolones. an overview on mechanistic aspects | journal = Current Medicinal Chemistry | volume = 8 | issue = 4 | pages = 371–84 | date = March 2001 | pmid = 11172695 | doi = 10.2174/0929867013373435 }}</ref><ref>{{cite journal | vauthors = Brouwers JR | title = Drug interactions with quinolone antibacterials | journal = Drug Safety | volume = 7 | issue = 4 | pages = 268–81 | year = 1992 | pmid = 1524699 | doi = 10.2165/00002018-199207040-00003 }}</ref>。

==別名==
它的别名有：环丙氟哌酸、奔克、丙氟哌酸、环丙沙星、健美灵、适普灵、特美力、悉复欢、悉普宁、西普乐、特美力、奎诺仙、环福星、全复康、速博新、Ciprofloxacin、Bay-O-9867、 CFLX、Ciproxin、Cifran、Temaril及CPFX等。<ref>{{Cite web |url=http://www.cnncio.com/shuomingshu/083834200831.html |title=存档副本 |accessdate=2010-03-22 |archive-date=2009-07-01 |archive-url=https://web.archive.org/web/20090701062735/http://www.cnncio.com/shuomingshu/083834200831.html |dead-url=no }}</ref>

== 参考资料 ==
{{reflist|2}}

==外部連結==
*[http://www.floxiehope.com Welcome to Floxie Hope] {{Wayback|url=http://www.floxiehope.com/ |date=20200829235818 }}
*[https://web.archive.org/web/20140502005207/http://www.bayer.ca/files/CIPRO-XL-PM-ENG-PT3-2AUG2013-165005.pdf CIPRO® XL(Ciprofloxacin hydrochloride and ciprofloxacin extended release tablets)]
*[http://www.myquinstory.info/wp-content/uploads/2010/01/FLOX_REPORT_REV_11.pdf QUINOLONE ANTIBIOTICS TOXICITY] {{Wayback|url=http://www.myquinstory.info/wp-content/uploads/2010/01/FLOX_REPORT_REV_11.pdf |date=20140211154443 }}

{{核酸合成抑制剂类抗生素}}
{{Otologicals}}
{{国家基本药物目录/抗微生物药}}
[[Category:拜耳|Category:拜耳]]
[[Category:喹诺酮抗生素|Category:喹诺酮抗生素]]
[[Category:环丙基化合物|Category:环丙基化合物]]
[[Category:Β-酮酸|Category:Β-酮酸]]